Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

Health Lobbying Means Cash Infusion For Candidates, TV StationsKaiser
"Health care groups working feverishly to shape -- or kill -- an industry-wide reform bill are lavishing campaign cash on the politicians at the center of the debate," The Salt Lake (Utah) Tribune reports. Sens. Orrin Hatch and Max Baucus, both major health reform players on the Senate Finance Committee, are among those benefiting form the uptick in contributions. One lobbyist for the watchdog group Public Citizen said, "A person can reach no other conclusion than this is quid pro quo activity" (Canham, 7/27).
generic viagra online
News From GP Conference, UK
GPs have warned that the reorganisation of health visitor services is putting children at risk and underlined the importance of them remaining in practice based teams. The call came at the Annual GPs Conference being held in London.
News of the day
University Of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed By Standard Hybridization Test
Results from a study published by the University of Michigan have shown that as many as 15% of women in the study group determined to be negative for the presence of human papillomavirus (HPV) in the cervix, via the most commonly used test for HPV DNA, may actually be infected with the virus at clinically relevant viral loads. PCR-MS detected the presence of high-risk HPV in nearly half (46.7%) of women who tested negative by the Hybrid Capture 2 (HC2) test, which is standard of care in many countries. Approximately 9,000 American women are diagnosed with cervical cancer each year despite regular cervical screening. The study, titled, Development and Evaluation of a PCR and Mass Spectroscopy-based (PCR-MS) Method for Quantitative, Type-specific Detection of Human Papillomavirus, will be published in the September 2009 edition of Journal of Virological Methods. The assay used in this study is exclusively licensed by SEQUENOM (Nasdaq: SQNM).
Oncology

Surgical Learning Curve For Laparoscopic Radical Prostatectomy: A Retrospective Cohort Study

UroToday.com - In the Lancet Oncology online edition, Dr. Andrew Vickers and collaborators report that prostate cancer (CaP) recurrence is significantly reduced with increasing surgical experience among urologists performing laparoscopic radical prostatectomy (LRP). The learning curve appears greater than that for open radical prostatectomy. In open RP analysis, the probability of a cancer recurrence decreased after 250-350 cases. In this multicenter, international retrospective cohort all patients had LRP without use of robotic assistance. A total of 4,702 patients treated between 1998 and 2007 were eligible for analysis. These patients were treated by one of 29 surgeons with 250 by 5 surgeons (17%). The number of prior open RPs were also counted; 0 cases in 45% of the 29 surgeons, 1-10 in 10%, 11-99 in 17%, 100-249 in 17%, and >250 in 10% of the 29 surgeons. Stratified by urologist experience, 30% of men were seen by a surgeon who had done less than 100 previous procedures, while half were seen by a surgeon with experience of more than 250 previous procedures. There was no correlation between surgeon experience and clinical variables, except for age with more experienced surgeons seeing slightly younger patients than less experienced surgeons. A total of 402 biochemical recurrences were recorded, for a 5-year recurrence-free probability of 82%. The risk of recurrence at 5 years decreased from 17% to 16% to 9% for a patient treated by a surgeon with 10, 250 and 750 previous LRPs, respectively. The risk difference between 10 and 750 procedures was 8%. Interestingly, surgeons with prior open RP experience had worse outcomes than surgeons with no prior open RP experience. For a surgeon with 100 previous open RPs, the relative risk increased at 5 years from 7.8% to 20.1%for an absolute risk difference of 12.3%. Vickers AJ, Savage CJ, Hruza M, Tuerk I, Koenig P, Martç­nez-Piç±eiro L, Janetschek G, Guillonneau B Lancet Oncol. 2009 May;10(5):475-80 Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009